Navigation Links
Cytos Reports Results from Phase I/IIa Study with CYT007-TNFQb for,the Treatment of Psoriasis

with substantial manufacturing costs and inconvenience for patients.

CYT007-TNFQb is a therapeutic vaccine in development for the treatment of psoriasis and other inflammatory conditions. It is designed to instruct the patient’s immune system to produce an anti- TNF-? antibody response. The induced antibodies aim to bind TNF-? in order to inhibit its inflammatory activity. That way, the subsequent inflammatory process should be slowed down and the deterioration of skin or other tissues reduced.

For further information please contact:
Cytos Biotechnology AG, Wagistrasse 25, CH-8952 Schlieren
Claudine Blaser, PhD
Director Corporate Communications
Tel.: +41 44 733 47 20
e-Mail: claudine.blaser@cytos.com
Webseite: www.cytos.com


About Cytos Biotechnology AG
Cytos Biotechnology AG is a public Swiss biotechnology company that specializes in the discovery, development and commercialization of a new class of biopharmaceutical products – the ImmunodrugsTM. ImmunodrugsTM are intended for use in the treatment and prevention of common chronic diseases, which afflict millions of people worldwide. ImmunodrugsTM are designed to instruct the patient’s immune system to produce desired therapeutic antibody or T cell responses that modulate chronic disease processes. Taking advantage of the high flexibility of its
ImmunodrugTM platform, Cytos Biotechnology has built a pipeline of different ImmunodrugTM candidates in various disease areas, of which 6 are currently in clinical development. The ImmunodrugTM candidates are developed both in-house and together with Novartis and Pfizer Animal Health. Founded in 1995 as a spin-off from the Swiss Federal Institute of Technology (ETH) in Zurich, the company is located in Schlieren (Zurich). Currently, the company has
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
2. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
3. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
4. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
5. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
6. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
7. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
8. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
9. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
10. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
11. Affymax Reports Phase 2 Clinical Dose Ranging Results of Once-Per-Month Hematide for the Treatment of Anemia
Post Your Comments:
(Date:12/1/2008)...O, Dec. 1 TargeGen has announced t...from a multi-center, US-based clinical,trial of T... been scheduled at,the 2008 American Society of H... presentation are as follows:, Title: ...vailable, JAK2-Selective I...
(Date:12/1/2008)...stinence is still the best policy , , ROCH...new study from Mayo Clinic finds the use of the dr...holic hepatitis, an acute inflammation of the live...results of the study are published in the December...urnal.org/ ). , , VIDEO ALERT: Additional ...
(Date:12/1/2008)...O, Dec. 1 Vical Incorpor... of a $1.0 million milestone payment from Merck &a...of a Phase I clinical trial of an investigational ...accine is based on Vical,s DNA gene delivery techn...iptase (hTERT). hTERT is the subject of separate l...
(Date:11/27/2008)...y finds the majority of acute lymphoblastic leukem... at the time of diagnosis , , MEMPHIS, Tenn...t St. Jude Children,s Research Hospital have ident...lls of children with acute lymphoblastic leukemia ...hway to designing treatments for ALL relapse in ch...
Breaking Medicine Technology:Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3Progress toward new storage media 8631 1Progress toward new storage media 8631 2Anadys Pharmaceuticals to Present at Bio Investor Forum 27824 1Anadys Pharmaceuticals to Present at Bio Investor Forum 27824 2MU researchers advance health communication for at risk populations 27821 1MU researchers advance health communication for at risk populations 27821 2Nuvo Research presents positive Phase III study results for Pennsaid at leading rheumatology conference 3354 1Nuvo Research presents positive Phase III study results for Pennsaid at leading rheumatology conference 3354 2Nuvo Research presents positive Phase III study results for Pennsaid at leading rheumatology conference 3354 3Nuvo Research presents positive Phase III study results for Pennsaid at leading rheumatology conference 3354 4
... Since the level of blood oxygenation can be an es... of hemoglobin levels in the clinical setting is o...o incorporate sophisticated technology into easily...several manufacturers offer prompt assessment of h..., Calif., says that its HemoCue Hemoglobin Test Sy...
... Although it may still seem radically innovative i...ated production in the manufacturing sector had be..., for example, automated lines fabricate sub-assem...an oversight. The result has been vastly improved ...ive returns in profit and productivity. These days...
Other Medicine Technology:Hemoglobin Testing at the Point of Care 2Hemoglobin Testing at the Point of Care 3Lab Automation Networks Proliferating 2Lab Automation Networks Proliferating 3Lab Automation Networks Proliferating 4
(Date:12/2/2008)...c. 2 Aduromed Industries...ider of medical waste treatment,systems, today an...n November,24, 2008 to protect the Company,s prop...rized MedClean Systems that provide a turnkey solu...tion and volume reduction. , The patent app...
(Date:12/2/2008)... Dec. 2 Genoptix, Inc. (...s provider, today announced the Company,s particip...onference scheduled to take place at the Westin Ne...08. , , Sam Riccitelli, COO and executive...anel discussion at the conference on Wednesday, De...
(Date:12/2/2008)...f., Dec. 2 In response to the comm..., Frequent Respiratory Infections, and the Vitamin... by 16 well known supplement experts, Nordic Natur...s pose no threat or compromise to consumers and ac...at are low in natural Vitamin A. According to Kari...
(Date:12/2/2008)...alif., Dec. 2 Internationally reco...as an invited speaker for this,year,s annual meet..., (Photo: http://www.newscom.com/cgi-bin/p...,Why is minimally invasive (or ,Goldilocks,) anest...tled ,PK 101, minimally invasive,anesthesia for m...
Breaking Medicine News(10 mins):Health News:Aduromed Files Patent Application to Cover Proprietary New Standard for Containerized, Turnkey Solution 2Health News:Aduromed Files Patent Application to Cover Proprietary New Standard for Containerized, Turnkey Solution 3Health News:Genoptix Announces Participation at the RBC Capital Markets 2008 Healthcare Conference 2Health News:Nordic Naturals Offers Cod Liver Oil Solutions in Response to Recent Vitamin A and Vitamin D Controversy 2
...ment has repeated its plea to doctors over prescri...could save ?85 millions in the coming year if GPs/... Primary Care Trusts (PCTs) can prescribe generic ...mvastatin, which are two of five ‘statin’ drugs th...
...exercise by doing household chores like dusting, m...east cancer, suggests a new study.// The research... women from nine European countries and found that... cancer protective than playing sport, reported th...
...s at the National Institutes of Health have discov...steogenesis //Imperfecta--a disorder that weakens ...lts from a genetic defect in a protein involved in...ted gene contains the information for cartilage as...
... your high blood pressure might just be your infla...dence suggests that inflammation, a part of the im...r, Alzheimer’s and diabetes, may also help transla...ressure. “There is a concept that hypertension is...
Other Medicine News:Health News:Researchers Discovered the Gene Responsible for Brittle Bone Disease 2Health News:Researchers Discovered the Gene Responsible for Brittle Bone Disease 3Health News:Inflammatory Genes Linked to Salt-Sensitive Hypertension 2Health News:Inflammatory Genes Linked to Salt-Sensitive Hypertension 3
The Medtronic StableMapr catheter is intended for use in diagnostic electrophysiologic procedures. These catheters are designed for recording intracardiac electrograms and temporary pacing associated
The Valve Mapper Steerocath-Dx has a unique "peanut" shaped tip. It is designed to conform to the anatomy during mapping procedures. Both 8F/8mm and 8F/6mm tips are available.
...heter is specifically designed for use with our CA...able NAVI-STAR catheter houses a Biosense Webster ..., exact location points from within the heart whil...rmation. The NAVI-STAR electro-anatomical navigati...
For Tricuspid Mapping. Biosense Webster offers a complete line of specialty 20-pole catheters for mapping in the atrium. The HALO XP 20-pole deflectable catheter is designed for simple placement and
Medicine Products: